Evotec's CEO Explains Logic Behind Drug Discovery Pact With Novo Nordisk
Executive Summary
Novo Nordisk's R&D pact with Evotec will open therapeutic possibilities for the Danish group in diabetes and obesity using small molecules, says Evotec's CEO.